Table 1. Treatment details and PBMC stimulation in each group.
|
Group |
Treatment |
|
1 |
PBMC + Concanavalin-A 1 µg/mL (Positive Inflammation Control) |
|
2 |
PBMC + DENV-1 + Antibody |
|
3 |
PBMC + DENV-1 + Antibody + FVP 2xIC50 |
|
4 |
PBMC + DENV-1 + Antibody + Quinine Sulfate 2xIC50 |